Delivery Order HHSD200201253709I-75D30122F00009
Award Date 9/29/22
Potential Completion Date 9/28/23
Potential Value $424K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost No Fee
Place of Performance
Roxbury, MA 02118, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Boston Medical Center Corporation (BMC), a private, not-for-profit academic medical center. The contract is a Delivery Order under the Clinical Immunization Safety Assessment (CISA) Master IDIQ, with a potential value of $728,754.00. BMC has provided clinical immunization safety assessment services to support the Department of Health and Human Services' immunization...
- This is a federal contract award to Boston Medical Center Corporation (BMC), a major safety-net hospital and academic medical center in Boston, Massachusetts. The contract was awarded by the Centers for Disease Control and Prevention (CDC) to provide Clinical Immunization Safety Assessment (CISA) services. The contract is a $742,721 delivery order under the CISA master IDIQ contract, which has a ceiling value of $86 million and runs from 2023 to 2028. The contract is not set aside. BMC is a...
- The CDC issued a delivery order to Boston Medical Center Corporation on September 28, 2023, with a ceiling value of $1,091,528, under the Clinical Immunization Safety Assessment (CISA) 2023–2028 IDIQ for clinical vaccine safety evaluation services contributing to Executive Order 14398. CISA is a CDC-administered indefinite delivery contract supporting clinical immunization safety assessments through September 2028. Place of performance is Roxbury, MA. The delivery order carries a cost-no-fee...
- The Department of Health and Human Services Centers for Disease Control and Prevention in Pittsburgh awarded a $56,102 purchase order to the Massachusetts Department of Public Health for the MASSACHUSETTS NDI 2021 program. As the prime contractor, the Massachusetts Department of Public Health will deliver services under this firm fixed price contract to support the Centers for Disease Control and Prevention's disease notification and investigation efforts in Massachusetts. Performance will occur...
- The Centers for Disease Control and Prevention, an agency of the Department of Health and Human Services, awarded a $9,990,604.91 firm fixed price definitive contract to Boston Children's Hospital for MIS-C in Children. As the prime contractor, Boston Children's Hospital will deliver services to investigate Multisystem Inflammatory Syndrome in Children (MIS-C), a condition where different body parts can become inflamed, including the heart, lungs, kidneys, brain, skin, eyes, or...
- <p>The CDC Pittsburgh issued a purchase order to the Massachusetts Department of Public Health on June 8, 2026, valued at $42,976.00, with performance completing May 1, 2027. Work is performed in Boston, Massachusetts. The order procures services under the 2026 NDI EO 14398 vehicle on a firm fixed-price basis. No set-aside applies to this award.</p>
- The Centers for Disease Control and Prevention (CDC Pittsburgh) awarded a $24.9 million definitive contract to The Children's Hospital Corporation, doing business as Boston Children's Hospital, for COVID-19 and MIS-C research under Executive Order 14398 on August 3, 2022, with no set-aside applied. Place of performance is Boston, MA. The contract is firm fixed price with an ultimate completion date of September 15, 2026. In fiscal 2024, the most recent reported period under Service Contract...
- Boston Medical Center Corporation is providing clinical trial network services under a $678,333 delivery order against the Contraceptive Clinical Trials Network-Female Sites contract vehicle through the National Institutes of Health National Institute of Child Health and Human Development. As the prime contractor, BMC will support the Evaluation of LARCs Study as a clinical research site. No set-aside designation was applied to this order to evaluate long-acting reversible contraceptive methods....
- The Centers for Disease Control and Prevention (CDC Pittsburgh) issued a delivery order to the Massachusetts Department of Public Health on February 27, 2026, with a ceiling value of $527,424, under the National Center for Health Statistics Vital Statistics Cooperative Program (NCHS VSCP). Place of performance is Boston, MA. The order carries a firm fixed price and runs through May 1, 2027. Work supports vital statistics data collection and analysis under the broader CDC Indefinite Delivery...
- <p>The Centers for Disease Control and Prevention, Atlanta (CDC Pittsburgh) issued a purchase order to Beth Israel Deaconess Medical Center, Inc. for $8,118.00 on July 1, 2026, for an EO 14398 HIV neutralizing antibody assay with an ultimate completion date of April 30, 2027. Work is performed in Boston, Massachusetts. The order is firm fixed price with no set-aside designation applied.</p>